Hybrid Healthcare Representative (Cebu South / Bohol / Dumaguete)

Posted:
7/29/2024, 5:00:00 PM

Location(s):
Makati, Metro Manila, Philippines ⋅ Metro Manila, Philippines

Experience Level(s):
Junior ⋅ Mid Level ⋅ Senior

Field(s):
Sales & Account Management

The Hybrid Healthcare Representative will be responsible for promoting and creating demand among identified specialists for the ethical products in the assigned territories to achieve sales and market share objectives.

Duties & Responsibilities:
• formulate strategies to achieve sales and market share objectives
• spearhead planning and implementation of all CME activities such as RTDs, webinars, symposia, product presentations within the assigned territories
• develop and maintain target specialists, speakers and key/emerging opinion leaders (KOLs/EOLs)
• develop and update Territory Master Work Plan (TMWP) as source of relevant information and guideline in planning MD calls and implementation of programs
• develop territory-based programs to improve understanding on assigned products
• monitor sales, product movements and competitor activities
• prepare and submit operational/admin reports
• perform other official duties and responsibilities that may be assigned from time to time by immediate superior
• adheres to company values and policies at all times

Qualifications Required:
• College graduate of a 4- or 5-year course
• With at least 2 years' experience as PHR
• Excellent communication skills (verbal and written)
• Good interpersonal skills
• With valid Med Rep PRC
• With valid driver's license

Willing to be Based in Cebu

Coverage Area: South Cebu Bohol & Dumaguete

#LI-PFE

  
Work Location Assignment: On Premise

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

Sales

Pfizer

Website: https://www.pfizer.com/

Headquarter Location: New York, New York, United States

Employee Count: 10001+

Year Founded: 1849

IPO Status: Public

Last Funding Type: Post-IPO Debt

Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine